ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Analysis of Survival and Neoplasm Recurrence in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: Association with Immunohistochemical Profile and Tumor Characteristics

    E. Ataide, R. Stucchi, T. Pereira, J. Almeida, C. Escanhoela, I. Boin

    Unit of Liver Transplantation, State University of Campinas, Campinas, São Paulo, Brazil

    Introduction: Although overall survival rates have been around 70% after five years, recurrence of hepatocellular carcinoma (HCC) has indices in literature ranging from 6 to…
  • 2013 American Transplant Congress

    Early Indicators of Kidney Graft Injury Mediated by Class II Donor Specific Antibodies (DSAII)

    E. Rodrigo, L. Cornell, B. Chopra, H. Amer, P. Dean, M. Stegall, F. Cosio

    Nephrology, Transplant Center, Mayo Clinic, Rochester, MN; Pathology, Transplant Center, Mayo Clinic, Rochester, MN; Surgery, Transplant Center, Mayo Clinic, Rochester, MN

    Introduction. Pre-transplant DSAII is associated with chronic antibody mediated rejection/transplant glomerulopathy (TG) and high risk of graft loss (GL). However, not all DSAII result in…
  • 2013 American Transplant Congress

    Expanding the Limits of the Expanded Criteria Donor

    L. Assis, M. Cristelli, T. Claudia, S. Miranda, M. Franco, T. Sandes-Freitas, M. Salenave, H. Tedesco, J. Medina- Pestana

    Nephrology Division, Hospital do Rim e Hipertensão, Sao Paulo, Brazil

    Background: Use of grafts from expanded criteria donors (ECD) has increased significantly in recent years. Acceptable reported outcomes may increase the limits of acceptance and…
  • 2013 American Transplant Congress

    Risk Factors in Venous Thrombosis of Renal Grafts from Deceased Non Heart-Beating Donors

    M. Molina, E. Gonzalez, N. Polanco, L. Garcia-Puente, A. Sevillano, E. Gutierrez, E. Morales, A. Hernandez, J. Morales, A. Andres

    Nephrology, Hospital 12 Octubre, Madrid, Spain

    Background: The deceased donor kidney transplant to non heart-beating may have a higher rate of venous thrombosis (VT).The aim of this study is to analyze…
  • 2013 American Transplant Congress

    Encapsulated Human Mesenchymal Stem Cells Reduce Alpha-Smooth Muscle Actin and Increase Matrix Metalloproteinase-9 Expression during Liver Fibrosis

    R. Meier, R. Mahou, P. Morel, Y. Muller, P. Christofilopoulos, C. Wandrey, C. Gonelle-Gispert, L. Buhler

    Visceral and Transplantation Surgery, Surgical Research Unit, Department of Surgery, University Hospitals of Geneva, Geneva University, Geneva, Switzerland; Laboratory of Chemical Biotechnology, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland; Orthopedic Surgery, University Hospitals of Geneva, Geneva University, Geneva, Switzerland

    INTRODUCTION: Mesenchymal stem cells (MSCs) transplantation has been suggested to be effective for the treatment of liver fibrosis, but the mechanisms of action are not…
  • 2013 American Transplant Congress

    Treg Express a Unique Pattern of Trafficking Molecules and Differentially Rely on LFA-1 for Migration Compared to Effector T Cells

    C. Brinkman, J. Bromberg

    University of Maryland, Baltimore

    Introduction: Selective interference with or enhancement of Treg function and/or migration are potentially therapeutically useful. However, to date the molecules which govern Treg migration seem…
  • 2013 American Transplant Congress

    KPC Infection – A Real Threat to Kidney Transplant Recipients

    M. Cristelli, G. Basso, E. Costa-Neto, D. Lopes, T. Sandes-Freitas, V. Silva, A. Gales, S. Moreira, H. Tedesco, J. Medina- Pestana

    Hospital do Rim e Hipertensão, Sao Paulo, Brazil

    Introduction: Carbapenemase-producing enterobacteriaceae (KPC) infection has become a world public health issue since its first detection in 1996. Intuitively, immunocompromised patients might be at higher…
  • 2013 American Transplant Congress

    Survival of Free and Encapsulated Islet Xenografts Transplanted in the Mouse Bone Marrow, The

    R. Meier, J. Seebach, P. Morel, R. Mahou, D. Bosco, T. Berney, L. Buhler, Y. Muller

    Visceral and Transplantation Surgery, Cell Isolation and Transplantation Center, Department of Surgery, University Hospitals of Geneva, Geneva University, Geneva, Switzerland; Division of Clinical Immunology and Allergology, Department of Internal Medicine, University Hospitals of Geneva, Geneva University, Geneva, Switzerland; Laboratory of Chemical Biotechnology, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland

    Objectives: Bone marrow (BM) has been recently shown to be an alternative and potentially immune-privileged site for islet transplantation. The aim of the study was…
  • 2013 American Transplant Congress

    Therapy with mTOR Inhibitors in Polyomavirus Nephropathy: A Five Year Follow Up

    A. Esteves, L. Camargo, L. Ulisses, G. Rivelli, M. Mazzali

    Division of Nephrology-School of Medical Sciences, State University of Campinas, Campinas, Sao Paulo, Brazil

    Background: Polyomavirus nephropathy (PVAN) has a negative impact on renal allograft survival, and its treatment remains controversial. Therapy options include reduction of immunosuppressive drugs and…
  • 2013 American Transplant Congress

    In Situ Quantification of 1,3-Galactosyl Transferase Knockout Swine Liver Protein Production Using Quantitative Comparative ELISA

    M. Hertl, I. Wamala, J. Fraser, Z. Machaidze, C. Schuetz, N. Elias, M. Varma, K. Kim, B. Cosimi, J. Markmann, D. Sachs

    Department of Surgery, MGH, Boston, MA; Transplant Biology Research Center, MGH, Charlestown, MA

    Background: Inception of GalT knock out (GalT-KO) miniature swine has helped to ameliorate rapid xenograft rejection, now allowing for investigations into the utility of miniature…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences